These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27584587)

  • 1. The management of multidrug-resistant Enterobacteriaceae.
    Bassetti M; Peghin M; Pecori D
    Curr Opin Infect Dis; 2016 Dec; 29(6):583-594. PubMed ID: 27584587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
    Bassetti M; Giacobbe DR; Robba C; Pelosi P; Vena A
    Curr Opin Infect Dis; 2020 Dec; 33(6):474-481. PubMed ID: 33060469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options for treating carbapenem-resistant Enterobacteriaceae.
    Rafailidis PI; Falagas ME
    Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: current evidence and future prospects.
    Sheu CC; Lin SY; Chang YT; Lee CY; Chen YH; Hsueh PR
    Expert Rev Anti Infect Ther; 2018 Mar; 16(3):205-218. PubMed ID: 29402125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
    D'Angelo RG; Johnson JK; Bork JT; Heil EL
    Expert Opin Pharmacother; 2016; 17(7):953-67. PubMed ID: 26891857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
    Falagas ME; Karageorgopoulos DE; Nordmann P
    Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
    Tängdén T; Giske CG
    J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of β-Lactamase Production and Colistin Resistance among Enterobacteriaceae Isolates from a Global Surveillance Program.
    Bradford PA; Kazmierczak KM; Biedenbach DJ; Wise MG; Hackel M; Sahm DF
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1385-92. PubMed ID: 26666920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
    Ng TM; Khong WX; Harris PN; De PP; Chow A; Tambyah PA; Lye DC
    PLoS One; 2016; 11(4):e0153696. PubMed ID: 27104951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.
    Tamma PD; Rodriguez-Bano J
    Clin Infect Dis; 2017 Apr; 64(7):972-980. PubMed ID: 28362938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options.
    Aslan AT; Akova M
    Expert Rev Anti Infect Ther; 2019 Dec; 17(12):969-981. PubMed ID: 31722185
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?
    Perez F; El Chakhtoura NG; Papp-Wallace KM; Wilson BM; Bonomo RA
    Expert Opin Pharmacother; 2016; 17(6):761-81. PubMed ID: 26799840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-Resistant Enterobacteriaceae.
    Iovleva A; Doi Y
    Clin Lab Med; 2017 Jun; 37(2):303-315. PubMed ID: 28457352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
    Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
    Sfeir MM; Askin G; Christos P
    Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.